Low Leverage / Strong Balance SheetVery low leverage and a high equity ratio give Hoshi Iryosanki durable financial flexibility. This balance-sheet strength supports investment in R&D or service capacity, buffers demand shocks in healthcare capital spending, and reduces refinancing risk over the next several quarters.

High Profitability And Operational EfficiencySustained gross and operating margins indicate strong pricing power and efficient cost control in medical-device manufacturing. These margin levels support reinvestment into product development and service networks while helping maintain cash generation even if top-line growth moderates.

After-sales Service Provides Recurring RevenueA revenue mix that includes maintenance, parts, and services creates annuity-like income tied to installed devices. That recurring component stabilizes cash flows between capital-equipment purchase cycles, strengthens customer stickiness, and improves visibility into multi-month service revenues.

Bears Say

Operating Cash-flow DeclineA year-over-year drop in operating cash flow hints at working-capital pressure or timing-related cash conversion issues. Even with FCF growth, weaker operating cash conversion raises the risk of cash volatility, which can constrain capex, R&D spending, or service expansion over the next several quarters.

Product Concentration In Respiratory CareHeavy reliance on respiratory-care equipment concentrates revenue on a narrow end market. Demand is sensitive to hospital upgrade cycles, public-health events, and reimbursement or regulatory shifts, limiting diversification and making medium-term growth vulnerable to sector dynamics.

Modest Return On EquityAn ROE of ~7.9% is modest given a strong equity base, suggesting limited capital efficiency. With substantial equity and low leverage, generating higher shareholder returns likely requires either faster profitable growth or improved asset deployment, which could be challenging in a specialized device niche.

7634 FAQ

What was Hoshi Iryosanki Co., Ltd.’s price range in the past 12 months?

Hoshi Iryosanki Co., Ltd. lowest stock price was ¥4250.00 and its highest was ¥5310.00 in the past 12 months.

What is Hoshi Iryosanki Co., Ltd.’s market cap?

Hoshi Iryosanki Co., Ltd.’s market cap is ¥16.04B.

When is Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date?

Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date is May 08, 2026 which is in 60 days.

How were Hoshi Iryosanki Co., Ltd.’s earnings last quarter?

Hoshi Iryosanki Co., Ltd. released its earnings results on Feb 09, 2026. The company reported ¥104.46 earnings per share for the quarter, beating the consensus estimate of N/A by ¥104.46.

Is Hoshi Iryosanki Co., Ltd. overvalued?

According to Wall Street analysts Hoshi Iryosanki Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hoshi Iryosanki Co., Ltd. pay dividends?

Hoshi Iryosanki Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 1.61%. See more information on Hoshi Iryosanki Co., Ltd. dividends here

What is Hoshi Iryosanki Co., Ltd.’s EPS estimate?

Hoshi Iryosanki Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hoshi Iryosanki Co., Ltd. have?

Hoshi Iryosanki Co., Ltd. has 3,420,000 shares outstanding.

What happened to Hoshi Iryosanki Co., Ltd.’s price movement after its last earnings report?

Hoshi Iryosanki Co., Ltd. reported an EPS of ¥104.46 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.806%.

Which hedge fund is a major shareholder of Hoshi Iryosanki Co., Ltd.?

Currently, no hedge funds are holding shares in JP:7634

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hoshi Iryosanki Co., Ltd.

Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It operates in five segments: Medical Gas-Related Business; Home Healthcare-Related Business; Medical Gas Equipment Construction-Related Business; Nursing-Care Related Business; and Facilities Nursing-Related Business. The Medical Gas-Related Business segment sells medical oxygen gas, anesthetic gas, and other medical gas. The Home Healthcare-Related Business segment rents oxygen concentrators for home oxygen therapy; and equipment for continuous positive airway pressure, home ventilators, etc. The Medical Gas Equipment Construction-Related Business segment designs and constructs medical gas piping construction, as well as maintenance and inspection of medical gas piping equipment. The Nursing-Care Related Business segment offers rental and sale of nursing care related products and equipment, home renovation, home-visit nursing, and in-home nursing care support services. The Facilities Nursing-Related Business segment operates fee-based nursing homes and day care facilities, as well as related operations. The company was founded in 1960 and is headquartered in Tokyo, Japan.